Dr. Shapiro on Preventative Drugs in Breast Cancer

Charles L. Shapiro, MD
Published Online: Monday, January 27, 2014
Charles L. Shapiro, MD, professor, College of Medicine, The James, Ohio State University Comprehensive Care Center, discusses the underutilization of preventative drugs for breast cancer.

Shapiro says preventative drugs in breast cancer are underutilized. There are many people that are considered high-risk for breast cancer but do not choose to take preventative drugs. Many people have a fear of side effects, Shapiro says, and will not take the risk of having side effects if they are not already diagnosed with cancer.

By increasing awareness of preventative drugs for this disease, Shapiro feels that a larger percentage of people who are at a higher risk for breast cancer would take these drugs.

Online CME Activities
Free CME from PER
Advances in Next-Generation Sequencing in Precision Oncology: Solid Tumors
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast Cancer
Newer Options on the Horizon for Non-Small Cell Lung Cancer
PARP Inhibitors: Current and Future Options for Breast and Ovarian Cancer
More Reading
$auto_registration$